Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial
Open Access
- 1 June 2010
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 10 (6), 1385-1393
- https://doi.org/10.1111/j.1600-6143.2009.02997.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT TrialTransplantation, 2009
- Keratotic Skin Lesions and Other Risk Factors Are Associated with Skin Cancer in Organ-Transplant Recipients: A Case–Control Study in The Netherlands, United Kingdom, Germany, France, and ItalyJournal of Investigative Dermatology, 2007
- Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassificationBritish Journal of Dermatology, 2007
- Subsequent Skin Cancers in Kidney and Heart Transplant Recipients after the First Squamous Cell CarcinomaTransplantation, 2006
- Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control seriesJournal of the American Academy of Dermatology, 2006
- Azathioprine and UVA Light Generate Mutagenic Oxidative DNA DamageScience, 2005
- Two‐year incidence of malignancy in sirolimus‐treated renal transplant recipients: results from five multicenter studies*Clinical Transplantation, 2004
- Skin Cancers after Organ TransplantationNew England Journal of Medicine, 2003
- A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neckJournal of the American Academy of Dermatology, 1991
- Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprineBritish Journal of Dermatology, 1989